Skip to main content
VNDA logo
VNDA
(NASDAQ)
Vanda Pharmaceuticals Inc.
$5.90-- (--)
Loading... - Market loading

Vanda Pharmaceuticals (VNDA) Stock Price & Financial Analysis

Vanda Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.93 - $6.11
52-Week High$9.94
52-Week Low$4.14
Open$5.97
Volume580.86K
Average Volume (3M)1.06M
Market Cap344.87M
Shares Outstanding59.46M
Price to Sales (P/S)1.58
Price to Book (P/B)1.23
EV/EBITDA-2.18
Revenue (TTM)217.78M
Net Income (TTM)-239.55M
Free Cash Flow (TTM)-127.30M
EPS (TTM)$-4.05
Profit Margin-109.99%
Operating Margin-73.64%
Return on Equity (ROE)-85.32%
Debt to Equity0.05
50-Day MA$6.55
200-Day MA$6.39
52-Week Change28.04%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Vanda Pharmaceuticals

What is the current stock price for VNDA?

As of the latest trading session, VNDA stock trades at $5.95. The 52-week range is $4.14–$9.94, with a day range of $5.93–$6.11.

What is the P/E ratio for VNDA?

The P/E ratio (Price-to-Earnings) for VNDA is shown in the Key Statistics section. This valuation metric helps compare Vanda Pharmaceuticals Inc. to industry peers.

Does VNDA pay dividends?

Vanda Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VNDA?

Based on 3 analysts, the consensus for VNDA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VNDA?

Vanda Pharmaceuticals's market capitalization is $353.8M, classifying it as a small-cap company. Vanda Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.